Dr Absar Khalid Mir, “EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY”, J Popl Ther Clin Pharmacol, vol. 31, no. 6, pp. 1059–1065, Jun. 2024, doi: 10.53555/jptcp.v31i6.6611.